Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
JUND | hg38_v1_chr19_-_18280806_18280929 | 0.21 | 2.5e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_153375591 Show fit | 4.39 |
ENST00000368737.5
|
S100 calcium binding protein A12 |
|
chr17_-_31318818 Show fit | 4.29 |
ENST00000578584.5
|
novel protein |
|
chr11_+_1864172 Show fit | 4.25 |
ENST00000446808.5
ENST00000509204.1 |
lymphocyte specific protein 1 novel transcript, sense overlapping LSP1 |
|
chr22_-_37149900 Show fit | 4.22 |
ENST00000216223.10
|
interleukin 2 receptor subunit beta |
|
chrX_+_78945332 Show fit | 4.11 |
ENST00000544091.1
ENST00000171757.3 |
P2Y receptor family member 10 |
|
chr1_+_160739286 Show fit | 4.02 |
ENST00000359331.8
ENST00000495334.1 |
SLAM family member 7 |
|
chr1_+_160739239 Show fit | 3.89 |
ENST00000368043.8
|
SLAM family member 7 |
|
chr1_+_116754422 Show fit | 3.76 |
ENST00000369478.4
ENST00000369477.1 |
CD2 molecule |
|
chr1_+_160739265 Show fit | 3.51 |
ENST00000368042.7
|
SLAM family member 7 |
|
chr4_-_83114715 Show fit | 3.39 |
ENST00000426923.2
ENST00000311507.9 ENST00000509973.5 |
placenta associated 8 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 12.1 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.1 | 9.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.9 | 7.3 | GO:0071725 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
0.1 | 6.2 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.2 | 5.4 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.3 | 5.3 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 4.8 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
1.2 | 4.7 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.1 | 4.4 | GO:0050832 | defense response to fungus(GO:0050832) |
0.4 | 4.2 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 12.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.6 | 7.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 6.2 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 5.1 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 5.1 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 4.9 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 4.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 3.9 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 3.8 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 3.4 | GO:0035578 | azurophil granule lumen(GO:0035578) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 7.3 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.0 | 6.9 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 5.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.7 | 5.6 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 4.8 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
1.6 | 4.7 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.2 | 4.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
1.1 | 4.2 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.2 | 3.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 3.1 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 7.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 7.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 6.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 5.6 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 4.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 4.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 3.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 3.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 3.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 3.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 10.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 10.0 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.4 | 8.3 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.1 | 5.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 5.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 5.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 5.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 4.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 3.5 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 3.3 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |